Cidara therapeutics CMO Davarpanah sells $29,796 in stock
NeutralFinancial Markets

Cidara Therapeutics' Chief Medical Officer, Davarpanah, has sold $29,796 worth of stock in the company.
Editor’s Note: This stock sale by a high-ranking executive may raise questions about the company's future, but it's not uncommon for executives to sell shares for various personal reasons.
— Curated by the World Pulse Now AI Editorial System